Efficacy of topical application of eosin for ulcerated hemangiomas - 08/08/11
Doi : 10.1016/j.jaad.2008.10.034
Moshe Lapidoth, MD a, c, Dan Ben-Amitai, MD b, c, Sulochana Bhandarkar, MD d, Levi Fried, BS d, Jack L. Arbiser, MD, PhD d, ⁎ 
a Department of Dermatology, Rabin Medical Center, Schneider Children’s Medical Center of Israel, Petah Tiqva, Israel
b Pediatric Dermatology Unit, Schneider Children’s Medical Center of Israel, Petah Tiqva, Israel
c Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
d Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia
Correspondence to: Jack L. Arbiser, MD, PhD, Department of Dermatology, Emory University School of Medicine, WMB 5309, 1639 Pierce Dr, Atlanta, GA 30322| Dr Arbiser was supported by the National Institutes of Health (grant RO1 AR47901) and an Emory Skin Disease Research Core Center Grant (P30 AR42687), a Veterans Administration Hospital Merit Award, and funds from the Jamie Rabinowitch-Davis Foundation for Melanoma Research and the Betty Minsk Foundation for Melanoma Research. |
|
| Conflicts of interest: None declared. |
© 2008
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 60 - N° 2
P. 350-351 - février 2009 Retour au numéro
Article précédent
- Goeckerman treatment for remission of psoriasis refractory to biologic therapy
- Rocco Serrao, Mark D.P. Davis
- Dermatitis herpetiformis flare associated with use of triiodomethane packing strips for alveolar osteitis
- Kenneth A. Katz, Julie E. Roseman, Robert L. Roseman, Stephen I. Katz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?